Drug-labels.com

VPI-Amikacin: Uses, Side Effects and Dosage

Status:
Prescription (Rx) Current status: Dormant Facts
Strength:
500 mg
Active ingredient:
ATC code:

Patient Medication Information: uses, side effects, how to take - VPI-Amikacin

What is VPI-AMIKACIN used for?

VPI-AMIKACIN is used to treat certain serious bacterial infections:

  • of the nose, throat, chest and lungs (respiratory tract)
  • in the blood
  • of the joints and bones
  • of the kidneys and urinary bladder (urinary tract)
  • of the lining of the abdomen (peritoneum)
  • of the soft tissues

Antibacterial drugs like VPI-AMIKACIN treat only bacterial infections. They do not treat viral infections. Although you may feel better early in treatment, VPI-AMIKACIN should be used exactly as directed. Misuse or overuse of VPI-AMIKACIN could lead to the growth of bacteria that will not be killed by VPI-AMIKACIN (resistance). This means that VPI-AMIKACIN may not work for you in the future.

How does VPI-AMIKACIN work?

VPI-AMIKACIN is an antibiotic. It works by killing or slowing the growth of certain types of bacteria that cause the infection.

What are the ingredients in VPI-AMIKACIN?

Medicinal ingredient: Amikacin as amikacin sulfate.

Non-medicinal ingredients: sodium metabisulfite, sodium citrate dihydrate, sulfuric acid to adjust pH and water for injection.

VPI-AMIKACIN comes in the following dosage forms:

VPI-AMIKACIN is a sterile aqueous solution containing 250 mg/mL of amikacin as amikacin sulfate.

Do not use VPI-AMIKACIN if you:

  • you are allergic to amikacin or any other ingredients in the drug (See What are the ingredients in VPI-AMIKACIN)
  • you are sensitive or allergic to other aminoglycosides

To help avoid side effects and ensure proper use, talk to your healthcare professional before you take VPI-AMIKACIN. Talk about any health conditions or problems you may have, including if you:

  • have been or are being treated with other aminoglycosides.
  • have drug allergies.
  • have kidney problems.
  • have hearing or balance problems.
  • have myasthenia gravis (a muscle condition) or Parkinson’s disease.
  • are pregnant or planning to become pregnant.

  • are breastfeeding or planning to breastfeed.
  • have asthma.
  • have sulfite sensitivity.

Other warnings you should know about:

  • VPI-AMIKACIN and other similar aminoglycosides have been known to cause hearing and balance problems (ototoxicity) and kidney problems (nephrotoxicity). Your doctor will observe you carefully for warning signs of these events after giving you VPI-AMIKACIN.
  • Your doctor may monitor the level of amikacin sulfate in your blood through blood tests, especially if you are taking, or have taken in the recent past, certain medications that can interact with VPI-AMIKACIN.
  • The safety for treatment periods which are longer than 14 days has not been established.
  • VPI-AMIKACIN, like many antibiotics, can cause Clostridium difficile colitis (bowel inflammation caused by a bacterial infection). If you experience symptoms such as severe diarrhea (bloody or watery) with or without fever, abdominal pain, or tenderness, you may have Clostridium difficile colitis (bowel inflammation). If this occurs, stop taking VPI-AMIKACIN and contact your doctor right away.

Tell your healthcare professional about all the medicines you take, including any drugs, vitamins, minerals, natural supplements or alternative medicines.

The following may interact with VPI-AMIKACIN:

  • Other antibiotics such as other aminoglycosides (e.g. gentamicin, neomycin, streptomycin, tobramycin), cephalosporins, clindamycin, imipenem, polymixin B, bacitracin, cephaloridine, colistin, paromomycin, penicillins and vancomycin.
  • Amphotericin B, a medicine used to treat severe fungal infections.
  • Anti-cancer drugs, such as cisplatin.
  • Potent diuretics, such as ethacrynic acid, furosemide and mannitol.
  • Neuromuscular blocking agents (muscle relaxants such as tubocurarine, succinylcholine and decamethonium)
  • Anesthetic agents such as those used during surgery
  • Any drug that may cause kidney or hearing problems. How to take VPI-AMIKACIN:

VPI-AMIKACIN will be given to you by a healthcare professional either as an injection into a muscle or injection into a vein at a hospital or clinical setting.

Usual Dose:

Your doctor will decide the dose that is right for you based on your age, weight and other factors. If you have kidney problems, your doctor may adjust the dosage schedule to suit you.

The usual dose of VPI-AMIKACIN is 7.5 mg/kg of body weight, given every 12 hours, for a total daily dose of 15 mg/kg of body weight, over a period of up to 10 days.

Overdose:

If you think you have been given too much VPI-AMIKACIN, contact your healthcare professional, hospital emergency department or regional poison control centre immediately, even if there are no symptoms.

Missed Dose:

VPI-AMIKACIN is administered by a healthcare professional. If you think you have missed a dose talk to your healthcare professional.

What are possible side effects from using VPI-AMIKACIN?

These are not all the possible side effects you may feel when taking VPI-AMIKACIN. If you experience any side effects not listed here, contact your healthcare professional.

Side effects may include:

  • rash
  • nausea, vomiting
  • allergic reaction, such as hives
  • difficulty breathing
  • headache
  • pain at injection site
  • fever
  • hypotension
  • anemia
  • tremor
  • joint pain

Serious side effects and what to do about them

Symptom / effectTalk to your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases

COMMON

Kidney Problems: blood in urine, change in frequency of urination or amount of urine, weakness, difficulty with breathing, drowsiness, increased thirst, loss of appetite, nausea, vomiting, fluid retention causing swelling of the legs, ankles or feet

Hearing Problems: trouble hearing or hearing loss with or without ringing in the ears, roaring in the ears, dizziness

UNKNOWN FREQUENCY

Nervous System Problems: numbness, skin tingling, muscle twitching, convulsions, seizure, trouble breathing

Serious Allergic Reaction (hypersensitivity):

swelling of the face, lips, tongue or throat, trouble breathing or swallowing, itching, hives, skin rash with or without blisters or peeling

Inner Ear Problems: loss of balance, dizziness or light-headedness, sensation of spinning, feeling of constant movement of self or surroundings
Clostridium difficile Colitis (bowel inflammation): severe diarrhea (bloody or watery) with or without fever, abdominal pain, or tenderness
Decreased Platelets: bruising, bleeding, fatigue and weakness
Decreased White Blood Cells: infections, fatigue, fever, aches, pains and flu-like symptoms

If you have a troublesome symptom or side effect that is not listed here or becomes bad enough to interfere with your daily activities, talk to your healthcare professional.

Reporting Side Effects

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction Reporting

    (https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/adverse-reaction-reporting.html) for information on how to report online, by mail or by fax; or

  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

Storage:

VPI-AMIKACIN vials should be stored between 15 and 30 ⁰C.

Keep out of sight and reach of children.

If you want more information about VPI-AMIKACIN:

  • Talk to your healthcare professional.
  • Find the full product monograph that is prepared for healthcare professionals and includes this Patient Medication Information by visiting the Health Canada website (https://health-products.canada.ca/dpd-bdpp/index-eng.jsp); the manufacturer’s website www.vpipharmainc.com; by email to the manufacturer at info@vpipharmainc.com; or by calling toll-free 1-855-782-0731.

Date prepared: October 13, 2020.

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02506599

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for VPI-Amikacin

Rx or OTC
Prescription (Rx)?
DIN 02506599
Schedule(s) PRESCRIPTION
Active ingredient(s) Amikacin (amikacin sulfate) 500 MG
Dosage form(s) Solution
Route(s) of administration Intramuscular, Intravenous
Drug class (WHO ATC)
  1. J Antiinfectives for systemic use
    1. J01 Antibacterials for systemic use
      1. J01G Aminoglycoside antibacterials
        1. J01GB Other aminoglycosides
          1. J01GB06 Amikacin
Company VPI PHARMACEUTICALS INC
Current status Dormant
Current status date July 13, 2023

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.